Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric rheumatology

4 ARP Members Talk About Their Roads to Advocacy & Why It Matters

From ARP Representatives to the ACR Government Affairs Committee  |  May 13, 2021

The Budget Control Act of 2011 cut Medicare physician payments by 2% across the board. The Coronavirus Aid, Relief, and Economic Security (CARES) Act, signed into law in 2020, suspended this sequester (i.e., a cut in government spending) between May 1 and Dec. 31, 2020. In the Consolidated Appropriations Act, signed into law in December…

Filed under:Interprofessional PerspectiveLegislation & Advocacy Tagged with:Association of Rheumatology Professionals (ARP)

Alisusha; Trueffelpix / shutterstock.com

3 New Vasculitis Guidelines Discussed

Ruth Jessen Hickman, MD  |  May 13, 2021

The ACR, in concert with the Vasculitis Foundation, released three new vasculitis guidelines online first in July, with a fourth slated for publication by the end of the year. These are the first ever to be produced and endorsed by the ACR and the Vasculitis Foundation. Although most of the recommendations are conditional, due to…

Filed under:Clinical Criteria/GuidelinesConditionsVasculitis Tagged with:AAV FocusRheumVasculitis Foundation

Case Report: Rapidly Progressive Interstitial Lung Disease in a 6-Year-Old

Anusha Vuppala, MD, & Sarwat Umer, MD  |  April 17, 2021

Clinically amyopathic dermatomyositis (CADM), a rare subset of dermatomyositis (DM), is an autoimmune disease characterized by cutaneous findings of typical DM without evidence of myositis. Childhood presentation of CADM is rare, and not many studies describe the epidemiology of juvenile CADM.1,2 Although lung disease is rare among patients with juvenile DM, a few reports have…

Filed under:ConditionsMyositis Tagged with:Clinically Amyotrophic Dermatomyositis (CADM)dermatomyositisinterstitial lung disease (ILD)juvenile dermatomyositisPediatric Rheumatology

COPA Syndrome: What Do We Know About This Rare Disease?

Lara C. Pullen, PhD  |  April 17, 2021

ACR CONVERGENCE 2020—Tiphanie Phillips Vogel, MD, PhD, assistant professor of pediatrics and internal medicine at Baylor College of Medicine, Houston, moderated the session on COPA syndrome, which drew 324 attendees on a Sunday morning. This rare genetic cause of immune dysregulation can present like anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis, lupus, lupus nephritis or rheumatoid…

Filed under:Conditions Tagged with:ACR Convergence 2020COPAgenetic diseasemimics

The ACR’s 2020 Advocacy Year in Review

Blair Solow, MD, & Zachary Wallace, MD, MSc  |  February 16, 2021

To say it has been an interesting (the science and the memes), tumultuous (the politics) and heartbreaking (the pandemic and social injustice) year is an understatement. There have been moments of grace and inspiration that we hope have kept everyone going.  As we look to 2021, we take lessons from our experiences in 2020. Washington,…

Filed under:From the CollegeLegislation & Advocacy Tagged with:Centers for Medicare & Medicaid Services (CMS)RheumPACstep therapytelehealthU.S. Congress

Diagnostic Drill-Down: New Research Suggests Genetic Autoinflammatory Roots

Mary Beth Nierengarten  |  January 25, 2021

Two experts discussed ongoing difficulties in diagnosing autoinflammatory disease, & promising new studies that point to possible genetic roots of autoinflammatory disease.

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2020autoinflammatory diseaseSAPHOSAPHO Syndromesystemic autoinflammatory diseases

A Pandemic of Psychological Distress Is Upon Us

Tamar Rubinstein, MD, Natoshia Cunningham, PhD, & Andrea Knight, MD, MSCE  |  January 20, 2021

It is nine months into the COVID-19 pandemic in the U.S. and the third wave is upon us, overwhelming hospital systems in many states across the country. But the alarms are being sounded for another looming pandemic as well. As early as spring 2020, significant increases were documented in the prevalence of depression and anxiety,…

Filed under:ConditionsPatient Perspective Tagged with:COVID-19Mental Health

ACR Advocacy: 2020 Year in Review

Blair Solow, MD  |  January 11, 2021

As a new year begins, Government Affairs Committee Chair Blair Solow, MD, takes stock of ACR advocacy wins in 2020 and issues to watch in 2021, including workforce issues, continued telemedicine access, prior authorization relief, Medicare reimbursement and drug pricing.

Filed under:American College of RheumatologyLegislation & Advocacy Tagged with:Blair SolowGovernment Affairs Committee (GAC)legislation and advocacy

The 2020 ACR Review Course: Key Issues Rheumatologists Face

Jason Liebowitz, MD, FACR  |  December 17, 2020

The ACR Review Course featured eight talks providing a practical review of issues encountered by rheumatologists.

Filed under:ACR ConvergenceConditionsMeeting ReportsOsteoarthritis and Bone DisordersPediatric ConditionsVasculitis Tagged with:ACR Convergence 2020liver diseasemeeting reportsOsteoporosisPediatricpregnancyVasculitis

The 2020 ARP Merit Awards & ACR Distinguished Fellows

Linda Childers  |  December 14, 2020

During ACR Convergence 2020 in early November, the ACR and ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARP Merit Awards and the ACR’s Distinguished Fellows. In addition, we bring you the first ever…

Filed under:Awards Tagged with:ACR Convergence 2020Anthony PerruccioAnthony S. FauciAssociation of Rheumatology Professionals (ARP)Dana VoinierDonah Zack CrawfordDr. Andrea FavaDr. Chio YokoseDr. Christine AnastasiouDr. Isaac T.W. HarleyDr. Nicole BitencourtDr. Patricia KatzDr. Rosemary PetersonDr. Ruth Fernandez-RuizDr. Sarah BaxterDr. Sarah FrenchDr. Stefanie WadeDr. Teresa J. BradyMaura IversenPaul AdamRoberta HortonScott Hasson

  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 95
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences